Table 1:
Characteristics of patients seen for OUD-related visits in study EDs
| Patient Characteristics | Overall (n=2665) |
Pre-Period (n=1326) |
Post-Period (n=1339) |
Delta | 95% CI |
|---|---|---|---|---|---|
| AGE, mean (SD) | 41.2 (14.3) | 41.5 (14.3) | 40.9 (14.2) | 0.6 | −0.47 to 1.69 |
| MALE GENDER, n (%) | 1771 (66.5) | 864 (65.1) | 907 (67.7) | 2.6% | −1.8 to 7.0 |
| HISPANIC ETHNICITY, n (%) | 147 (5.5) | 67 (5.1) | 80 (6.0) | 0.9% | −6.5 to 8.3 |
| RACE, n (%) | |||||
| White | 1471 (55.1) | 709 (52.5) | 762 (56.9) | 4.4% | −0.7 to 9.5 |
| Black/African American | 1085 (40.7) | 576 (43.4) | 509 (38.0) | −5.4% | −11.2 to 0.4 |
| Asian/Pacific Islander | 22 (1.3) | 14 (1.1) | 8 (0.6) | −0.5% | −8.1 to 7.1 |
| Other/Unknown | 87 (3.3) | 27 (2.0) | 60 (4.5) | −.5% | −4.9 to 9.9 |
| INSURANCE STATUS, n (%) | |||||
| Medicaid | 1664 (62.4) | 801 (60.4) | 863 (64.5) | 4.1% | −0.6 to 8.8 |
| Medicare | 351 (13.2) | 192 (14.5) | 159 (11.9) | −2.6% | −9.7 to 4.5 |
| Commercial | 426 (16.0) | 219 (16.5) | 207 (15.5) | −1.0% | −8.0 to 6.0 |
| Uninsured/Unknown | 224 (8.4) | 114 (8.6) | 110 (8.2) | −0.4% | −7.7 to 6.9 |
| COMBORBIDITIES, n (%) | |||||
| Depression | 96 (3.6) | 52 (3.9) | 44 (3.3) | −0.6% | −8.1 to 6.9 |
| Anxiety | 83 (3.1) | 26 (2.0) | 57 (4.3) | 2.3% | −5.3 to 9.9 |
| Bipolar Disorder | 24 (0.9) | 4 (0.3) | 20 (1.5) | 1.2% | −6.8 to 3.8 |
| Schizophrenia | 21 (0.8) | 9 (0.7) | 12 (0.9) | 0.2% | −7.4 to 7.8 |
| Stimulant Use Disorder | 158 (5.9) | 81 (6.1) | 77 (5.8) | −0.3% | −7.7 to 7.1 |
| Alcohol Use Disorder | 106 (4.0) | 53 (4.0) | 53 (4.0) | 0% | −7.5 to 7.5 |
| Benzodiazepine/Sedative Use Disorder | 62 (2.3) | 38 (2.9) | 24 (1.8) | −1.1% | −8.6 to 6.4 |
| CHARLSON, mean (SD) | 0.9 (1.9) | 0.90 (1.9) | 0.85 (1.9) | 0.1 | −0.1 to 0.2 |
| PREVIOUS ED Visit in last 12 months, *mean (SD) | 3.5 (10.1) | 3.9 (11.1) | 3.2 (8.8) | 0.7 | −0.10 to 1.5 |
| PREVIOUS HOSPITAL ADMISSIONS in last 12 months, mean (SD) | 0.40 (1.55) | 0.35 (1.52) | 0.45 (1.57) | −0.10 | −0.22 to 0.02 |